Shares of McKesson Co. (NYSE:MCK) have received an average rating of “Hold” from the fifteen brokerages that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and six have issued a buy recommendation on the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $137.99.
Several analysts have recently issued reports on the stock. ValuEngine lowered shares of McKesson from a “sell” rating to a “strong sell” rating in a research note on Friday. Zacks Investment Research upgraded shares of McKesson from a “hold” rating to a “buy” rating and set a $144.00 target price for the company in a research note on Monday, February 4th. Barclays reiterated a “hold” rating and issued a $130.00 target price on shares of McKesson in a research note on Friday, February 1st. Deutsche Bank upgraded shares of McKesson from a “sell” rating to a “hold” rating and set a $175.00 target price for the company in a research note on Friday, January 25th. Finally, UBS Group assumed coverage on shares of McKesson in a research note on Thursday, January 17th. They issued a “neutral” rating and a $134.00 target price for the company.
Get McKesson alerts:Shares of NYSE MCK traded down $2.63 during trading on Monday, hitting $124.53. The stock had a trading volume of 1,549,119 shares, compared to its average volume of 1,566,529. McKesson has a 12 month low of $106.11 and a 12 month high of $160.87. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.02 and a quick ratio of 0.57. The firm has a market cap of $25.22 billion, a price-to-earnings ratio of 9.87, a PEG ratio of 1.37 and a beta of 1.25.
McKesson (NYSE:MCK) last posted its earnings results on Thursday, January 31st. The company reported $3.40 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.18 by $0.22. McKesson had a negative net margin of 0.15% and a positive return on equity of 27.83%. The firm had revenue of $56.21 billion during the quarter, compared to analyst estimates of $55.27 billion. During the same quarter in the prior year, the business posted $3.41 EPS. On average, research analysts anticipate that McKesson will post 13.55 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Monday, April 1st. Investors of record on Friday, March 1st will be issued a $0.39 dividend. This represents a $1.56 dividend on an annualized basis and a dividend yield of 1.25%. The ex-dividend date is Thursday, February 28th. McKesson’s dividend payout ratio (DPR) is currently 12.36%.
In related news, EVP Lori A. Schechter sold 7,700 shares of the business’s stock in a transaction dated Wednesday, January 16th. The shares were sold at an average price of $122.96, for a total value of $946,792.00. Following the transaction, the executive vice president now directly owns 10,000 shares of the company’s stock, valued at approximately $1,229,600. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.87% of the stock is currently owned by insiders.
Several large investors have recently modified their holdings of the stock. Proficio Capital Partners LLC lifted its holdings in McKesson by 161.2% during the fourth quarter. Proficio Capital Partners LLC now owns 222 shares of the company’s stock valued at $25,000 after purchasing an additional 137 shares during the last quarter. Bedel Financial Consulting Inc. lifted its holdings in McKesson by 165.2% during the fourth quarter. Bedel Financial Consulting Inc. now owns 236 shares of the company’s stock valued at $26,000 after purchasing an additional 147 shares during the last quarter. Old North State Trust LLC lifted its holdings in McKesson by 53.3% during the fourth quarter. Old North State Trust LLC now owns 391 shares of the company’s stock valued at $43,000 after purchasing an additional 136 shares during the last quarter. IMS Capital Management purchased a new stake in McKesson during the third quarter valued at about $57,000. Finally, Financial Gravity Companies Inc. purchased a new stake in McKesson during the fourth quarter valued at about $57,000. 87.31% of the stock is currently owned by institutional investors.
About McKesson
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
See Also: Cost of equity and a company's balance sheet
No comments:
Post a Comment